Published in Medical Devices and Surgical Technology Week, November 7th, 2004
Addressing the second annual Australian Biotechnology Expo at the Australian Stock Exchange in Sydney, Australia, Ventracor's Business Development and Clinical Director and the co-inventor of its VentrAssist left ventricular assist system (LVAS), Dr John Woodard, said:
"With our trial for European approval now well underway and recruitment proceeding very well, we are looking to begin our U.S....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week